This Week in HIV Research: Renal Upsides for Tenofovir Alafenamide

This Week in HIV Research: Renal Upsides for Tenofovir Alafenamide

1 of 5
Next >

HIV research: It does a body good! As we drank in the latest in peer-reviewed HIV science for this week's article, we found a host of studies whose findings are likely to yield benefits for the minds and bodies of our HIV-positive patients and clients. They include new data regarding:

  • The viability of the single-pill E/C/F/TAF regimen in HIV-positive people on chronic hemodialysis.
  • Tenofovir alafenamide's safety in the setting of kidney damage among people who took the prodrug's predecessor.
  • Mental health concerns and critical screening needs among HIV-positive American Indians and Alaskan Natives.
  • The importance of fully appreciating and servicing the parenting desires of people living with HIV.

Let's pour ourselves a hearty glass of research, and help one another grow up to be big and strong HIV care providers. To beat HIV, you have to follow the science!

Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.

Myles Helfand is the executive editor and general manager of TheBody and TheBodyPRO. Follow Myles on Twitter: @MylesatTheBody.

Image Credit: Stefan Kühn; licensed under CC BY-SA 3.0

HIV research: It does a body good! As we drank in the latest in peer-reviewed HIV science for this week's article, we found a host of studies whose findings are likely to yield benefits for the minds and bodies of our HIV-positive patients and clients. They include new data regarding:

  • The viability of the single-pill E/C/F/TAF regimen in HIV-positive people on chronic hemodialysis.
  • Tenofovir alafenamide's safety in the setting of kidney damage among people who took the prodrug's predecessor.
  • Mental health concerns and critical screening needs among HIV-positive American Indians and Alaskan Natives.
  • The importance of fully appreciating and servicing the parenting desires of people living with HIV.

Let's pour ourselves a hearty glass of research, and help one another grow up to be big and strong HIV care providers. To beat HIV, you have to follow the science!

Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.

Myles Helfand is the executive editor and general manager of TheBody and TheBodyPRO. Follow Myles on Twitter: @MylesatTheBody.

Image Credit: Stefan Kühn; licensed under CC BY-SA 3.0